Health Canada drug identification number

DIN 02515490 — VYXEOS 100 MG; 44 MG

VYXEOS is a powder of Daunorubicin / Cytarabine marketed by JAZZ PHARMACEUTICALS IRELAND LIMITED. The full Daunorubicin / Cytarabine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02515490
Brand name
VYXEOS
Active ingredient
Daunorubicin / Cytarabine
Strength
100 MG; 44 MG
Dosage form
POWDER
Route
INTRAVENOUS
Manufacturer
JAZZ PHARMACEUTICALS IRELAND LIMITED
Health Canada status
MARKETED
Drug class
Liposomal anthracycline / antimetabolite antineoplastic combination

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.